Protalix BioTherapeutics, Inc.: Form DEF 14A, filed Sep 20, 2013
Filed with the SEC on Sep 20, 2013 and accepted by EDGAR at Sep 19, 2013, 19:04 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001144204-13-051645. Last ingested by Listed: Nov 10, 2026, 16:48 ET. Listed shows no prices and gives no investment advice.